Vincent Dong, None;
Duriye Damla Sevgi, None;
Sudeshna Sil Kar, None;
Sunil K. Srivastava, Abbvie (C), Allergan (F), Allergan (C), Eyepoint (F), Eyepoint (C), Eyevensys (F), Eyevensys (C), Gilead (C), Leica (P), Novartis (C), Regeneron (F), Regeneron (C), Santen (F), Zeiss (C);
Justis Ehlers, Adverum (C), Aerpio (F), Aerpio (C), Alcon (F), Alcon (C), Allegro (C), Allergan (F), Allergan (C), Boehringer-Ingelheim (F), Genentech (F), Genentech/Roche (C), Leica (C), Leica (P), Novartis (F), Novartis (C), Regeneron (F), Regeneron (C), Santen (C), Stealth (C), Thrombogenics/Oxurion (F), Thrombogenics/Oxurion (C), Zeiss (C);
Anant Madabhushi, Aiforia Inc. (C), AstraZeneca (F), Boehringer-Ingelheim (F), Bristol Meyers-Squibb (F), Elucid Bioimaging (I), Elucid Bioimaging (P), Inspirata Inc. (I), Inspirata Inc. (F), PathCore Inc. (F), Philips (F)